EOLS
Evolus Inc
Price:  
6.63 
USD
Volume:  
1,539,442.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-368.9%
Upside

As of 2025-09-16, the Relative Valuation of Evolus Inc (EOLS) is (17.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.63 USD, the upside of Evolus Inc based on Relative Valuation is -368.9%.

The range of the Relative Valuation is (17.35) - (18.00) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.2x - 18.8x 18.6x
Forward P/E multiples 18.1x - 19.3x 18.6x
Fair Price (17.35) - (18.00) (17.83)
Upside -361.6% - -371.5% -368.9%
6.63 USD
Stock Price
(17.83) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2025-09-15 -6.92
2025-09-12 -7.50
2025-09-11 -7.84
2025-09-10 -7.67
2025-09-09 -7.71
2025-09-08 -7.94
2025-09-05 -7.99
2025-09-04 -7.84
2025-09-03 -7.70
2025-09-02 -7.83
2025-08-29 -7.96
2025-08-28 -7.85
2025-08-27 -7.91
2025-08-26 -7.98
2025-08-25 -7.75
2025-08-22 -8.01
2025-08-21 -7.75
2025-08-20 -7.54
2025-08-19 -7.44
2025-08-18 -6.98
2025-08-15 -7.02
2025-08-14 -6.68
2025-08-13 -6.79
2025-08-12 -6.68
2025-08-11 -6.02
2025-08-08 -6.16
2025-08-07 -6.33
2025-08-06 -6.65
2025-08-05 -9.30
2025-08-04 -9.51
2025-08-01 -9.55
2025-07-31 -9.31
2025-07-30 -9.35
2025-07-29 -9.65
2025-07-28 -9.68
2025-07-25 -9.94
2025-07-24 -10.07
2025-07-23 -10.00
2025-07-22 -9.99
2025-07-21 -9.62
2025-07-18 -9.60
2025-07-17 -9.75
2025-07-16 -9.60
2025-07-15 -9.67
2025-07-14 -9.92
2025-07-11 -9.89
2025-07-10 -10.15
2025-07-09 -10.08
2025-07-08 -9.66
2025-07-07 -9.54